Literature DB >> 10985709

Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

J G Webb1, L A Sleeper, C E Buller, J Boland, A Palazzo, E Buller, H D White, J S Hochman.   

Abstract

OBJECTIVES: We sought to examine the implications of the timing of onset of cardiogenic shock (CS) after acute myocardial infarction (MI).
BACKGROUND: Little information is available about the relationships between timing, clinical substrate, management and outcomes of shock.
METHODS: The multinational SHOCK Trial Registry enrolled MI patients with CS from 1993 to 1997. Cardiogenic shock was predominantly attributable to left ventricular (LV) failure in 815 Registry patients for whom temporal data were available. We examined factors related to the timing of shock onset and the relation of temporal onset to in-hospital outcomes.
RESULTS: Overall, shock developed a median of 6.2 h after MI symptom onset. Shock onset varied by culprit artery: left main, median 1.7 h; right, 3.5 h; circumflex, 3.9 h; left anterior descending (LAD), 11.0 h; saphenous vein graft, 10.9 h (p = 0.025). Early shock (< 24 h) occurred in 74.1% and was associated with chest pain at shock onset, ST-segment elevation in two or more leads, multiple infarct locations, inferior MI, left main disease and smoking. Late shock (> or = 24 h) was associated with recurrent ischemia, Q waves in two or more leads and LAD culprit vessel. Mortality was higher in patients with early versus late shock (62.6% vs. 53.6%, p = 0.022).
CONCLUSIONS: Shock onset after acute MI occurred within 24 h in 74% of the patients with predominant LV failure. Mortality was slightly higher in patients developing shock early rather than later. Many factors influence when shock develops, which has implications for its management.

Entities:  

Mesh:

Year:  2000        PMID: 10985709     DOI: 10.1016/s0735-1097(00)00876-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  20 in total

Review 1.  [Therapy of cardiogenic shock after myocardial infarction].

Authors:  M Ferrari; H R Figulla
Journal:  Internist (Berl)       Date:  2008-09       Impact factor: 0.743

Review 2.  Management of refractory cardiogenic shock.

Authors:  Alex Reyentovich; Maya H Barghash; Judith S Hochman
Journal:  Nat Rev Cardiol       Date:  2016-06-30       Impact factor: 32.419

Review 3.  Evaluation and Management of ST-elevation Myocardial Infarction and Shock.

Authors:  Lee Chang; Robert Yeh
Journal:  Eur Cardiol       Date:  2014-12

Review 4.  Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy.

Authors:  Stephen Westaby; Rajesh Kharbanda; Adrian P Banning
Journal:  Nat Rev Cardiol       Date:  2011-12-20       Impact factor: 32.419

Review 5.  Pathophysiology, diagnosis, and treatment of infarction-related cardiogenic shock.

Authors:  M Buerke; H Lemm; S Dietz; K Werdan
Journal:  Herz       Date:  2011-03       Impact factor: 1.443

6.  Therapeutic strategies for cardiogenic shock, 2006.

Authors:  Troy C Ellis; Eli Lev; Naji F Yazbek; Neal S Kleiman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-02

Review 7.  New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs.

Authors:  A V Schally; K Szepeshazi; A Nagy; A M Comaru-Schally; G Halmos
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

Review 8.  [Cardiogenic shock: pathophysiology, clinics, therapeutical options and perspectives].

Authors:  R Prondzinsky; K Werdan; M Buerke
Journal:  Internist (Berl)       Date:  2004-03       Impact factor: 0.743

9.  Decade-Long Trends (2001-2011) in the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial Infarction.

Authors:  Robert J Goldberg; Raghavendra Charan P Makam; Jorge Yarzebski; David D McManus; Darleen Lessard; Joel M Gore
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-02-16

10.  Therapeutic Strategies for Cardiogenic Shock.

Authors:  Naji F. Yazbek; Neal S. Kleiman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.